tenk.fyi

EXOZYMES INC.

EXOZNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$9.2M

56.3% YoY

EPS

$-1.09

22.5% YoY

Cash

$3.0M

68.7% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.

Upgrade to Pro